Doxazosin
- Product NDC
- 50090-5540
- 11-digit product format
- 500905540
- Labeler code
- 50090
- Product ID
- 50090-5540_ab3b89f9-8742-43db-881c-e988f8603a7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2017-07-10
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5540-0 | 50090554000 | 30 TABLET in 1 BOTTLE (50090-5540-0) | 30 tablet | 2021-05-10 | 0000-00-00 | No | No | Current |